Literature DB >> 164235

The removal of cholesterol from aortic smooth muscle cells in culture and Landschutz ascites cells by fractions of human high-density apolipoprotein.

Y Stein, M C Glangeaud, M Fainaru, O Stein.   

Abstract

Ascites cells were labeled by intraperitoneal injection of [3H]cholesterol and aortic smooth muscle cells by addition of [3H]cholesterol to the serum component of the culture medium. The release of cholesterol from cells into a serum-free medium supplemented with the various "acceptors" was studied using ascites cells in suspension and aortic smooth muscle cells in a multilayer culture. Unfractionated human high-density apolipoprotein was somewhat more effective in the removal of labeled cellular free cholesterol, in both cell types, than apolipoprotein derived from rat high-density lipoprotein. Following separation of human high-density apolipoprotein into four fractions by Sephadex chromatography, the effect of each fraction on the removal of cellular cholesterol from ascites cells was studied. The individual fractions had a lower capacity for cholesterol removal than the original unfractionated high-density apolipoprotein and the lowest activity was detected in Fraction II which comprised 75% of the total apolipoprotein. The effectiveness to remove cholesterol could be restored to all the fractions, as well as enhanced, by addition of sonicated suspensions of lecithin or sphingomyelin, which by themselves promoted a more limited removal of cellular cholesterol. Negatively stained preparations of mixtures of the four fractions and sonicated dispersion of lecithin were shown to consist of vesicles and discs of various sizes. Addition of the apolipoprotein fractions (especially Fractions II and IV) to sonicated dispersion of sphingomyelin resulted in a pronounced formation of discs which showed a high tendency towards stack formation. Mixtures of Fraction II and lecithin or sphingomyelin were effective in the release of cellular cholesterol from multilayers of aortic smooth muscle cells in culture. These results show the feasibility of net removal of cholesterol from cells which grow in a form resembling a tissue and thus provide a model to study the role of apolipoprotein-phospholipid mixtures in cholesterol removal from cells and tissues in vivo.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 164235     DOI: 10.1016/0005-2760(75)90049-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  32 in total

Review 1.  Model systems in cell culture for the study of atherogenesis Heinrich Wieland Award Lecture.

Authors:  Y Stein; O Stein
Journal:  Klin Wochenschr       Date:  1979-09-03

2.  Apolipoproteins in rat serum and renal lymph.

Authors:  P S Roheim; D Edelstein; G G Pinter
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

3.  Interaction between high density and low density lipoproteins uptake and degradation by cultured human fibroblasts.

Authors:  N E Miller; D B Weinstein; T E Carew; T Koschinsky; D Steinberg
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

4.  High-density and low-density lipoproteins and prevalence of vascular disease in diabetes mellitus.

Authors:  J P Reckless; D J Betteridge; P Wu; B Payne; D J Galton
Journal:  Br Med J       Date:  1978-04-08

Review 5.  Cholesterol metabolism in man.

Authors:  S M Grundy
Journal:  West J Med       Date:  1978-01

6.  [Etiology and pathogenesis of arteriosclerosis].

Authors:  G Schettler; H Mörl
Journal:  Naturwissenschaften       Date:  1978-03

7.  [Tangier-disease (author's transl)].

Authors:  G Assmann
Journal:  Klin Wochenschr       Date:  1979-01-15

8.  Relationship between plasma insulin levels and high density lipoprotein cholesterol levels in healthy men.

Authors:  M Stalder; D Pometta; A Suenram
Journal:  Diabetologia       Date:  1981-12       Impact factor: 10.122

9.  Central role of high density lipoprotein in plasma free cholesterol metabolism.

Authors:  C C Schwartz; Z R Vlahcevic; M Berman; J G Meadows; R M Nisman; L Swell
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

10.  Identification of a cDNA clone for mouse apoprotein A-1 (apo A-1) and its use in characterization of apo A-1 mRNA expression in liver and small intestine.

Authors:  J C Miller; R K Barth; P H Shaw; R W Elliott; N D Hastie
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.